{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-010296","form_type":"8-K","ticker":"BLGO","cik":"0000880242","company_name":"BIOLARGO, INC.","filed_at":"2025-03-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.635633+00:00","generated_at":"2026-05-24T02:44:16.943293+00:00","sec_items":["7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"BioLargo reports record 2024 revenues of $17.8M, up 45% YoY; net loss narrows 6%","bullets":["Revenue $17.779M, up 45% from 2023; tenth consecutive year of revenue growth.","Net loss $4.347M, down 6% YoY; $3.490M of loss from Clyra Medical operations.","Issued 42% fewer shares in 2024 vs 2023; cash and equivalents $3.548M at Dec 31.","Clyra surgical irrigation products progressing toward national rollout with distribution partner.","Non-cash expenses (stock/options) $2.479M, representing 57% of net loss."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-010296","json":"https://secwatch.observer/filing/0001437749-25-010296.json","markdown":"https://secwatch.observer/filing/0001437749-25-010296.md","text":"https://secwatch.observer/filing/0001437749-25-010296.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/880242/000143774925010296/0001437749-25-010296-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/880242/000143774925010296/blgo20250331_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T02:44:16.943293+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}